Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes

Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes

Mitsuyoshi Takahara,1 Toshihiko Shiraiwa,2 Taka-aki Matsuoka,3 Kaoru Yamamoto,2 Yoshifumi Maeno,2 Yuka Shiraiwa,2 Yoko Yoshida,2 Naoto Katakami,4 Hiroaki Iijima,5 Hideyuki Katsumata,6 Kenji Arakawa,5 Toshio Hashimoto,5 Iichiro Shimomura3 1Department of Diabetes Care Medicine, Osaka University Gradua...

Full description

Bibliographic Details
Main Authors: Takahara M, Shiraiwa T, Matsuoka TA, Yamamoto K, Maeno Y, Shiraiwa Y, Yoshida Y, Katakami N, Iijima H, Katsumata H, Arakawa K, Hashimoto T, Shimomura I
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
beta cell function
canagliflozin
glimepiride
glycemic control
type 2 diabetes mellitus
Online Access:https://www.dovepress.com/investigation-of-the-effect-of-canagliflozin-on-the-disposition-index--peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/investigation-of-the-effect-of-canagliflozin-on-the-disposition-index--peer-reviewed-article-DMSO

Similar Items